Back to All Events

Vaccines and Related Biological Products Advisory Committee

On Thursday, March 1, 2018, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) made recommendations on the selection of strains to be included in the influenza virus vaccine for the 2018 to 2019 influenza season in the US. The Committee agreed with the World Health Organization (WHO) strain recommendations for the 2018-2019 Northern Hemisphere influenza season.
In the first part of the meeting, the Committee heard an overview of the research program in the Laboratory of Mucosal Pathogens and Cellular Immunology (LMPCI), Division of Bacterial, Parasitic and Allergenic Products (DBPAP), Office of Vaccines Research and Review (OVRR), Center for Biologics Evaluation and Research (CBER), FDA.